Status:
COMPLETED
Sudden Cardiac Death in Systemic Right Ventricle
Lead Sponsor:
European Georges Pompidou Hospital
Collaborating Sponsors:
KU Leuven
Erasmus Medical Center
Conditions:
Sudden Cardiac Death
Congenital Heart Disease
Eligibility:
All Genders
16+ years
Brief Summary
In complete transposition of the great arteries (TGA) with previous atrial switch repair, and congenitally corrected transposition of the great arteries (ccTGA), the morphological right ventricle and ...
Detailed Description
1 Registry design The registry is a retrospective multicentric registry that involves the collection of demographics, clinical, imaging data, electrophysiological and laboratory of patients with a sR...
Eligibility Criteria
Inclusion
- patients \>16 years of age
- sRV and a transposition of the great arteries (TGA or ccTGA) with "two-ventricle circulation"
Exclusion
- congenital heart diaese with univentricular heart physiology
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
1240 Patients enrolled
Trial Details
Trial ID
NCT03833843
Start Date
September 1 2018
End Date
September 1 2019
Last Update
May 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Europen Georges Pompidou
Paris, France, 75015